| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 37 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 37 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 37 |
| 3 | PREDNISONE | 25 |
| 4 | RITUXIMAB | 22 |
| 5 | CYTARABINE | 21 |
| 6 | DOXORUBICIN | 19 |
| 7 | DOCETAXEL | 17 |
| 8 | DOCETAXEL ANHYDROUS | 17 |
| 9 | BLINATUMOMAB | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAGRAXOFUSP | 1 | 0.0019 |
| 1 | CHLORAMBUCIL | 6 | 0.0015 |
| 2 | BLINATUMOMAB | 15 | 0.0014 |
| 3 | DECITABINE | 6 | 0.0014 |
| 4 | CLOFARABINE | 3 | 0.0013 |
| 5 | GEMTUZUMAB OZOGAMICIN | 4 | 0.0011 |
| 6 | BENDAMUSTINE HYDROCHLORIDE | 8 | 0.0009 |
| 7 | CLADRIBINE | 9 | 0.0009 |
| 8 | IDARUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| 9 | MITOXANTRONE HYDROCHLORIDE | 5 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 38 |
| 1 | Corticosteroid [EPC] | 37 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 36 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 22 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 20 |
| 5 | Microtubule Inhibitor [EPC] | 17 |
| 6 | BCL-2 Inhibitor [EPC] | 15 |
| 7 | Platinum-based Drug [EPC] | 12 |
| 8 | Kinase Inhibitor [EPC] | 10 |
| 9 | Purine Antimetabolite [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 1 | CD33-directed Immunoconjugate [EPC] | 4 | 0.0011 |
| 2 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 4 | BCL-2 Inhibitor [EPC] | 15 | 0.0002 |
| 5 | Alkylating Drug [EPC] | 38 | 0.0002 |
| 6 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 36 | 0.0001 |
| 8 | Microtubule Inhibitor [EPC] | 17 | 0.0001 |
| 9 | Purine Antimetabolite [EPC] | 10 | 0.0001 |